RinGlar®

RinGlar®
Product Description

Insulin glargine. 

Dosage form: solution for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.

·         Long-acting basal insulin
·         Maintains normal physiologic concentration of basal (background) insulin
·         Most widely used basal insulin analogue. Is the reference product for all basal insulins.
·         Increased duration of action of insulin glargine is associated with subcutaneous microprecipitate generation from which small amounts of insulin glargine permanently release, which makes it possible to administer the product once a day.
·         Concentration: U100
·         Onset of action after subcutaneous administration – in 1 hour
·         29 hours – maximum action
·         24 hours – duration of action

Geropharm

  • RU
  • 2019
    On CPHI since
Specifications
  • Supplied from
    Russian Federation

Geropharm

  • RU
  • 2019
    On CPHI since

More Products from Geropharm (2)

  • RinLis®  Mix 25

    Product RinLis® Mix 25

    Insulin lispro biphasic 25.Dosage form: susupension for subcutaneous injections in 3 ml cartridges and pre-filled disposable insulin pen.

    ·         Has fast and predictable effect and the elimination typical for physiologic insulin secretion.
    ·&nb...
  • RinLis®

    Product RinLis®

    Insulin lispro. 
    Dosage form: solution for subcutaneous and intravenous injections in 3 ml cartridges and disposable insulin pen. 

    ·         Widely used fast acting insulin analogue.
    ·       &...

Geropharm resources (1)